COVID-19 cases can result in serious illness, hospitalizations and deaths. Monoclonal antibody (mAb) therapies can help prevent severe illness, save lives, and reduce the burden on our hospitals and health systems. This therapy is available through shots or IV infusion, making it easier for providers to give and patients to get. mAb therapies can be used as treatment for confirmed positive patients and as prevention after a COVID-19 exposure.
Due to limitations in supply, Oregon Health Authority (OHA) is working to equitably distribute our federal allocation, which is updated weekly.
Weekly federal allocations and provider requests
Sites listed below are those receiving shipments of mAb therapies in the most recent week. Sites may redistribute their allocation to other providers. This list is not indicative of how much product a location may have available at any given time. If you are seeking mAb therapy for yourself, please contact your provider.
Sites receiving mAb therapy
Allocations are prioritized to ordering sites weekly, based on the following considerations:
- Federally Qualified Health Centers & Tribal Health Clinics, which serve communities disproportionately impacted by COVID-19
- County-level COVID-19 hospitalizations & cases
- Sites located in communities disproportionately impacted by COVID-19 (utilizing COVID-19 Community Vulnerability Index)
- Site-level weekly utilization rate
Download the list
Ordering link for registered providers